Indefinite Delivery Contract SPE2DU25D5130

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp valued at up to $4,999,999 through December 2036. This single-award IDC will serve as a prime vendor contract to provide worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as medical supplies, to the Department of Defense, U.S. Coast Guard, and other federal agencies. The contract encompasses normal day-to-day operations, planned and unplanned contingencies, and war readiness requirements for delivery to both CONUS and OCONUS locations. The DLA intends to make multiple primary supplier awards across regional line items, with at least three different contractors selected, to ensure resiliency and access to critical pharmaceuticals. The contract will be a firm-fixed-price, requirements-type contract with a 30-month base period and three 30-month option periods, for a total estimated value of $30.3 billion. Awards will be made on a lowest price technically acceptable basis, with a reverse auction used to determine final distribution fees.

The original pre-solicitation notice indicates that DLA Troop Support is planning to issue a solicitation in March 2024 to establish Pharmaceutical Prime Vendor Global Program Generation V contracts. The procurement will be unrestricted and fully competitive, with the intent to award multiple primary suppliers for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, as well as a separate backup supplier. The contracted pharmaceutical and medical products will cover the 6505 stock catalog/schedule and the current National Drug Code database, supporting normal operations as well as contingency and war readiness requirements for the DoD and other federal customers.